ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Quince Therapeutics Inc

Quince Therapeutics Inc (QNCX)

0.9199
0.0119
(1.31%)
Closed May 16 4:00PM
0.9199
0.00
(0.00%)
After Hours: 6:15PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
0.9199
Bid
0.8905
Ask
0.93
Volume
23,939
0.90 Day's Range 0.93
0.84 52 Week Range 1.74
Market Cap
Previous Close
0.908
Open
0.90
Last Trade
248
@
0.9199
Last Trade Time
Financial Volume
$ 21,800
VWAP
0.910635
Average Volume (3m)
78,077
Shares Outstanding
42,868,947
Dividend Yield
-
PE Ratio
-1.26
Earnings Per Share (EPS)
-0.73
Revenue
-
Net Profit
-31.39M

About Quince Therapeutics Inc

Quince Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on advancing precision therapeutics designed to precisely deliver small molecules, peptides, and large molecules directly to the site of bone diseases to promote more rapid healing with fewer off-target safety con... Quince Therapeutics, Inc. operates as a biopharmaceutical company. The Company focuses on advancing precision therapeutics designed to precisely deliver small molecules, peptides, and large molecules directly to the site of bone diseases to promote more rapid healing with fewer off-target safety concerns. Quince Therapeutics serves customers in the United States. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Wilmington, Delaware, USA
Founded
1970
Quince Therapeutics Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker QNCX. The last closing price for Quince Therapeutics was $0.91. Over the last year, Quince Therapeutics shares have traded in a share price range of $ 0.84 to $ 1.74.

Quince Therapeutics currently has 42,868,947 shares outstanding. The market capitalization of Quince Therapeutics is $39.44 million. Quince Therapeutics has a price to earnings ratio (PE ratio) of -1.26.

QNCX Latest News

Quince Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company developing an innovative drug delivery technology designed to leverage a patient’s own biology to deliver rare disease...

Quince Therapeutics to Present at The Citizens JMP Life Sciences Conference

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company developing an innovative drug delivery technology designed to leverage a patient’s own biology to deliver rare disease...

Quince Therapeutics Provides Business Update and Reports Fourth Quarter and Fiscal 2023 Financial Results

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company developing an innovative drug delivery technology designed to leverage a patient’s own biology to deliver rare disease...

Quince Therapeutics Launches Scientific Advisory Board

World-renowned scientists and clinicians to provide expert insight and advice to support advancement of the company’s lead Phase 3 asset, new indications, and pipeline expansion Quince...

Quince Therapeutics Appoints Former Reata Pharmaceuticals Chief R&D Officer Dr. Rajiv Patni to its Board of Directors

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company developing an innovative drug delivery technology that leverages a patient’s own biology to deliver rare disease...

Quince Therapeutics to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference

Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company developing an innovative drug delivery technology that leverages a patient’s own biology to deliver rare disease...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.01992.211111111110.91.010.89961108710.92120089CS
4-0.0801-8.0111.120.8996982620.98418919CS
12-0.4101-30.83458646621.331.420.89780771.05679731CS
260.01151.265962131220.90841.43010.84856371.10517899CS
52-0.6001-39.48026315791.521.740.841395921.21104019CS
156-35.5201-97.475576289836.44121.980.540161632010.79919432CS
260-24.0901-96.321871251525.01121.980.540142972915.19918323CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CRKNCrown Electrokinetics Corporation
$ 0.2321
(402.38%)
3.12B
LSDILucy Scientific Discovery Inc
$ 1.5697
(207.78%)
69.27M
GWAVGreenwave Technology Solutions Inc
$ 0.149
(149.16%)
1.93B
TOIIWOncology Institute Inc
$ 0.0998
(134.82%)
6.38k
FFIEFaraday Future Intelligent Electric Inc
$ 1.6401
(132.64%)
1.14B
LGHLWLion Group Holding Ltd
$ 0.0041
(-28.07%)
40
SYTASiyata Mobile Inc
$ 2.51
(-27.87%)
622.62k
REKRRekor Systems Inc
$ 1.3811
(-24.12%)
5.92M
EYENEyenovia Inc
$ 0.8156
(-23.06%)
1.65M
RELIReliance Global Group Inc
$ 0.29
(-21.60%)
2.97M
CRKNCrown Electrokinetics Corporation
$ 0.2321
(402.38%)
3.12B
GWAVGreenwave Technology Solutions Inc
$ 0.149
(149.16%)
1.93B
FFIEFaraday Future Intelligent Electric Inc
$ 1.6401
(132.64%)
1.14B
PEGYPineapple Energy Inc
$ 0.1467
(68.81%)
472.39M
SINTSiNtx Technologies Inc
$ 0.139999
(9.72%)
381.41M

QNCX Discussion

View Posts
Monksdream Monksdream 2 months ago
QNCX
👍️0
Monksdream Monksdream 3 months ago
QNCX under $2
👍️0
AKATITUS AKATITUS 5 months ago
Slow climber
👍️0
Monksdream Monksdream 7 months ago
QNCX under $2
👍️0
AKATITUS AKATITUS 10 months ago
Bought some 1.10s
See what happens
👍️0
knrorrel knrorrel 10 months ago
News https://www.stocktitan.net/news/QNCX/quince-therapeutics-to-acquire-ery-del-sp-a-and-its-phase-3-asset-02yx0yj60e08.html
👍️0
AJ Freely AJ Freely 10 months ago
$QNCX - Up 10% Pre-Market/ Current Price $1.75
To Acquire EryDel SpA and its Phase 3 Asset Targeting Ataxia-Telangiectasia with No Currently Approved Treatments and Estimated $1+ Billion Peak Sales Opportunity
👍️0
AJ Freely AJ Freely 10 months ago
$QNCX- Up 26% Pre-Market/ Current Price $1.24
Echo Lake Capital Increase Offer to Acquire Quince Therapeutics
Increases offer to $1.80 per share + CVR to receive 85% of the future net proceeds of Quince as part of the Lighthouse Pharmaceuticals transaction
👍️0
alchemytrader alchemytrader 1 year ago
Happens. Dirty diluting CEOs
👍️0
Backstabbed Backstabbed 1 year ago
Sorry to hear that
👍️0
alchemytrader alchemytrader 1 year ago
not true. i lost my ass trying to swing PSFE HLBZ FUV. took a terrible loss after finally fiving up. Had i held on i would have lost 90-99% of my money.
👍️0
Backstabbed Backstabbed 1 year ago
all about patience. they all run eventually
👍️0
alchemytrader alchemytrader 1 year ago
congrats
👍️0
Backstabbed Backstabbed 1 year ago
$QNCX - added today!
👍️0
Backstabbed Backstabbed 1 year ago
nice. very low PPS here after it hit a high of $1.75 in PM last week
👍️0
Sirpeter Sirpeter 1 year ago
Hi buddy...added it to watch
👍️0
Backstabbed Backstabbed 1 year ago
$QNCX - News out!!! Quince Therapeutics Provides Pipeline Update and Business Outlook for 2023
👍️0
tw0122 tw0122 1 year ago
$1.33 running again
👍️0
saj saj 1 year ago
Mid 1.3's nice pop on news
👍️0
makinezmoney makinezmoney 1 year ago
$QNCX: Decent bounce move here..... now 0.74


2 days now back to back....................... it was receding since Summer last ear and now finally going


On WATCH


GO $QNCX
👍️0
cash4 cash4 2 years ago
https://www.otcmarkets.com/filing/html?id=15980132&guid=AKk-kW7ZRh7-B3h
👍️0